Holger Stark

Holger Stark (2018) Holger Stark (born on September 15, 1962) is a German pharmacist and a Professor at Heinrich Heine University in Düsseldorf. Stark is a co-inventor of the active ingredient Pitolisant, the only histamine H3 receptor antagonist approved to date. Provided by Wikipedia
Showing 1 - 6 results of 6 for search 'Holger Stark', query time: 0.03s Refine Results
  1. 1
    Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism

    Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model... by Nermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, Priya Yuvaraju, Markus Falkenstein, Holger Stark, Bassem Sadek

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H<sub>3</sub>R Ligands with Antioxidant Properties

    First Report on Cationic Triphenylphosphonium Compounds as Mitochondriotropic H<sub>3</sub>R Ligands with Antioxidant Properties by Tobias Werner, Tito Añazco, Paula Osses-Mendoza, Alejandro Castro-Álvarez, Cristian O. Salas, Raquel Bridi, Holger Stark, Christian Espinosa-Bustos

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Substituted Purines as High-Affinity Histamine H<sub>3</sub> Receptor Ligands

    Substituted Purines as High-Affinity Histamine H<sub>3</sub> Receptor Ligands by Christian Espinosa-Bustos, Luisa Leitzbach, Tito Añazco, María J. Silva, Andrea del Campo, Alejandro Castro-Alvarez, Holger Stark, Cristian O. Salas

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease

    Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer's disease by Donia E. Hafez, Mariam Dubiel, Gabriella La Spada, Marco Catto, David Reiner-Link, Yu-Ting Syu, Mohammad Abdel-Halim, Tsong-Long Hwang, Holger Stark, Ashraf H. Abadi

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Guanidines: Synthesis of Novel Histamine H<sub>3</sub>R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect

    Guanidines: Synthesis of Novel Histamine H<sub>3</sub>R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect by Marek Staszewski, Magdalena Iwan, Tobias Werner, Marek Bajda, Justyna Godyń, Gniewomir Latacz, Agnieszka Korga-Plewko, Joanna Kubik, Natalia Szałaj, Holger Stark, Barbara Malawska, Anna Więckowska, Krzysztof Walczyński

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo Evaluation

    Dual Targeting Ligands-Histamine H<sub>3</sub> Receptor Ligands with Monoamine Oxidase B Inhibitory Activity-In Vitro and In Vivo Evaluation by Dorota Łażewska, Agata Siwek, Agnieszka Olejarz-Maciej, Agata Doroz-Płonka, Anna Wiktorowska-Owczarek, Marta Jóźwiak-Bębenista, David Reiner-Link, Annika Frank, Wioletta Sromek-Trzaskowska, Ewelina Honkisz-Orzechowska, Ewelina Królicka, Holger Stark, Marek Wieczorek, Waldemar Wagner, Katarzyna Kieć-Kononowicz, Anna Stasiak

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: